Pazhani G P, Ramamurthy T, Mitra U, Bhattacharya S K, Niyogi S K
Department of Microbiology, National Institute of Cholera and Enteric Diseases, Kolkata, India.
Epidemiol Infect. 2005 Dec;133(6):1089-95. doi: 10.1017/S0950268805004498.
The incidence, phenotypic characteristics and antimicrobial resistance patterns of 193 Shigella strains isolated from 2489 hospitalized children with acute diarrhoea were studied during January 2001 to August 2004. S. flexneri (60%) was the most prevalent serogroup, followed by S. sonnei (23.8%), S. dysenteriae (9.8%) and S. boydii (5.7%). Since 2002, S. flexneri 2a was the most dominant serotype. Almost all S. flexneri strains exhibited resistance to ampicillin, co-trimoxazole, tetracycline, nalidixic acid and fluoroquinolones. After a lapse of almost 14 years, S. dysenteriae type 1 strains reemerged for the first time during 2002 and these strains were resistant to more than two antibiotics (multidrug resistance), including fluoroquinolones. An upsurge of similar resistance patterns was also noted among S. flexneri type 2a since December 2003. Resistance to fluoroquinolone increased year on year among S. dysenteriae type 1 and S. flexneri, but not in S. boydii or S. sonnei. Monitoring of antimicrobial susceptibility through a surveillance programme is recommended to select appropriate antibiotics for the effective treatment of shigellosis in this region.
2001年1月至2004年8月期间,对从2489名住院急性腹泻儿童中分离出的193株志贺氏菌菌株的发病率、表型特征及抗菌药物耐药模式进行了研究。福氏志贺氏菌(60%)是最常见的血清群,其次是宋内志贺氏菌(23.8%)、痢疾志贺氏菌(9.8%)和鲍氏志贺氏菌(5.7%)。自2002年以来,福氏2a志贺氏菌是最主要的血清型。几乎所有福氏志贺氏菌菌株都对氨苄西林、复方新诺明、四环素、萘啶酸和氟喹诺酮类耐药。时隔近14年后,1型痢疾志贺氏菌菌株于2002年首次重新出现,这些菌株对两种以上抗生素(多重耐药)耐药,包括氟喹诺酮类。自2003年12月以来,在福氏2a志贺氏菌中也注意到类似耐药模式的激增。1型痢疾志贺氏菌和福氏志贺氏菌对氟喹诺酮类的耐药性逐年增加,但鲍氏志贺氏菌或宋内志贺氏菌未出现这种情况。建议通过监测计划监测抗菌药物敏感性,以便选择合适的抗生素有效治疗该地区的志贺氏菌病。